News UChicago, Duality Teams to Pitch at 2021 Chicago Venture Summit Several teams from the University of Chicago and Duality – the world’s first accelerator focused exclusively on quantum technologies – pitched at the 2021 Chicago Venture Summit. The venture capital...
Technology Next-Generation Immunotherapy Platform With Engineered Collagen-Binding Cytokine Combinations Combination engineered IL-7 and IL-12 proteins that target tumors by binding to collagen, boosting immune attack on cancer while reducing side effects and improving long-term protection, even in cancers resistant…
Technology Engineered Cytokine-Receptor System For Enhanced Cancer And Viral Infection Treatment The technology enhances cytokine signaling and immune function, optimizing the antiviral and anti-cancer efficacy of Type III IFNs by adjusting cytokine-receptor interaction affinity and relative JAK geometry, providing an effective…
Technology Fully Synthetic Adjuvant Delivery System For Enhanced Tumor-Targeted Immunotherapy A cancer vaccine that enhances immune response by directly binding adjuvants to tumor cells, avoiding targeting antibodies, and reducing related side effects The problem: Therapeutic vaccination has long been a…
